Hangzhou AGS MedTech Co. Ltd. A - Asset Resilience Ratio
Hangzhou AGS MedTech Co. Ltd. A (688581) has an Asset Resilience Ratio of 18.93% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Hangzhou AGS MedTech Co. Ltd. A carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Hangzhou AGS MedTech Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688581 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Hangzhou AGS MedTech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hangzhou AGS MedTech Co. Ltd. A (688581) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥500.86 Million | 18.93% |
| Total Liquid Assets | CN¥500.86 Million | 18.93% |
Asset Resilience Insights
- Good Liquidity Position: Hangzhou AGS MedTech Co. Ltd. A maintains a healthy 18.93% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Hangzhou AGS MedTech Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Hangzhou AGS MedTech Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Vieworks Co. Ltd
KQ:100120 |
Medical Devices | 7.81% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 9.40% |
|
Humasis Co. Ltd
KQ:205470 |
Medical Devices | 52.35% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
aap Implantate AG
F:AAQ1 |
Medical Devices | 3.55% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Annual Asset Resilience Ratio for Hangzhou AGS MedTech Co. Ltd. A (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Hangzhou AGS MedTech Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 26.32% | CN¥671.22 Million ≈ $98.22 Million |
CN¥2.55 Billion ≈ $373.11 Million |
+22.79pp |
| 2023-12-31 | 3.54% | CN¥82.42 Million ≈ $12.06 Million |
CN¥2.33 Billion ≈ $341.11 Million |
-8.09pp |
| 2022-12-31 | 11.63% | CN¥55.01 Million ≈ $8.05 Million |
CN¥473.13 Million ≈ $69.23 Million |
+11.31pp |
| 2021-12-31 | 0.32% | CN¥1.09 Million ≈ $159.70K |
CN¥341.99 Million ≈ $50.04 Million |
-- |
About Hangzhou AGS MedTech Co. Ltd. A
Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; an… Read more